🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of the study was to evaluate the efficacy (blood pressure lower...
Status
Completed
Location
Investigative Site
Start Date
2010-10
Trial ID
NCT01237223
This study evaluated the effect of early initiation of aliskiren therapy, c...
Status
Completed
Location
Novartis Investigative Site
Start Date
2009-05
Trial ID
NCT00894387
This prospective multicenter, double blind study will evaluate the efficacy...
Status
Completed
Location
Novartis Investigative Site
Start Date
2009-11
Trial ID
NCT01042392
Treatments Being Tested
The core and extension studies assessed the safety and efficacy of aliskire...
Status
Completed
Location
Novartis US
Start Date
2006-12
Trial ID
NCT00414609
In addition to the blood pressure lowering effects of aliskiren, it may hav...
Status
Completed
Location
Novartis Investigator Site
Start Date
2009-05
Trial ID
NCT00923156
Treatments Being Tested
This study is designed to compare the blood pressure lowering efficacy of a...
Status
Withdrawn
Location
Multiple Locations
Start Date
2015-05
Trial ID
NCT01922141
Treatments Being Tested
The study is designed to primarily assess the effect of aliskiren on albumi...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2011-01
Trial ID
NCT01302899
This study compared the blunting effect of aliskiren and valsartan monother...
Status
Completed
Location
Investigative Site
Start Date
2009-02
Trial ID
NCT00819767
Treatments Being Tested
This extension study will assess the safety and efficacy of AIN457 versus p...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2010-08
Trial ID
NCT01090310
Part 1 determined: aliskiren, amlodipine and angiotensin II concentrations ...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2007-06
Trial ID
NCT00498433
Treatments Being Tested